Whitney Meier’s practice focuses on complex patent litigation with an emphasis in the chemical and pharmaceutical arts. Her experience includes work on foreign patent opposition proceedings and inter partes review proceedings before the United States Patent and Trademark Office. Whitney's practice also includes many aspects of trademark law, including clearing and prosecuting U.S. and foreign trademarks.
While in law school, Whitney served as the Trade Editor for the Georgetown Journal of International Law and a student intern for the Honorable Francisco A. Besosa, United States District Court, District of Puerto Rico.
Eli Lilly & Company and ImClone Systems LLC v. Genetech, Inc. and City of Hope
Achieved favorable settlement for Eli Lilly and ImClone in case regarding the Cabilly biotechnology patents and Erbitux®, a therapy for colorectal and head and neck cancer.